Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Clinical and Experimental Medicine|August 4, 2025
Emerging CAR immunotherapies: broadening therapeutic horizons beyond cancerNatthaporn Sueangoen, Somsak PrasongtanakijCell & Bioscience|March 20, 2020
HCC-derived EGFR mutants are functioning, EGF-dependent, and erlotinib-resistantNatthaporn Sueangoen, Anchalee Tantiwetrueangdet, Ravat PanvichianInternational Journal of Molecular Medicine|June 21, 2024
Public neoantigens in breast cancer immunotherapy (Review)Natthaporn Sueangoen, Peti Thuwajit, Pa-Thai Yenchitsomanus, et al.Medical Oncology (Northwood, London, England)|October 5, 2018
Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissuesAnchalee Tantiwetrueangdet, Ravat Panvichian, Sansanee Wongwaisayawan, et al.Medical Oncology (Northwood, London, England)|August 18, 2018
Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissuesAnchalee Tantiwetrueangdet, Ravat Panvichian, Pattana Sornmayura, et al.Cancer Cell International|September 30, 2017
Blocking ERK1/2 signaling impairs TGF-β1 tumor promoting function but enhances its tumor suppressing role in intrahepatic cholangiocarcinoma cellsPhaijit Sritananuwat, Natthaporn Sueangoen, Parichut Thummarati, et al.International Journal of Molecular Sciences|January 28, 2026
Anticancer Activity of 2,3'-Dihydroxy-5'-Methoxystilbene Against NSCLC Cell Lines Through AKT-Dependent Mechanisms: A Comprehensive In Vitro and Computational AnalysisPhisit Pouyfung, Nonthalert Lertnitikul, Noriyoshi Ogino, et al.Cancer Immunology, Immunotherapy : CII|February 13, 2024
Stimulating T cell responses against patient-derived breast cancer cells with neoantigen peptide-loaded peripheral blood mononuclear cellsNatthaporn Sueangoen, Harald Grove, Nisa Chuangchot, et al.Pageof 1